glp 1 resistant food research Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss Beyond the Hype: How GLP-1

Although long-acting glucagon-like peptide-1 (GLP-1) analogues are now in routine use for diabetes and are now being utilised for obesity per se , the need for ever better treatments has driven the development of co-agonists, with the theoretical advantages of improved efficacy by targeting multiple pathways and reduced adverse effects

Verified against PubMed and ScienceDirect

Growth hormone release is significant and consistent

The researchers wondered whether the genetic glitch also affects GLP-1, a gut hormone that plays an important role in blood sugar control after a meal by stimulating insulin release, slowing stomach emptying and reducing appetite